Director, Head of NBE DMPK Project Support
Darmstadt, Hessen, Germany
Kyra Cowan is a Director in Research and Development at Merck KGaA, leading as the Head of New Biological Entities Drug Metabolism and Pharmacokinetics (NBE DMPK) Project Support, managing a group of scientific directors to represent the pharmacokinetic, bioanalytical, and immunogenicity strategies and scientific expertise across the large molecule portfolio, from early discovery to life cycle management. Prior to joining Merck, she was a drug development lead and bioanalytical scientist at Genentech in South San Francisco, California, where she served on and led teams for molecules in multiple therapeutic areas. She received a Ph.D. in Chemistry from Carleton University (Ottawa, Canada), and completed two postdoctoral fellowships, including one at the University of California, San Francisco, prior to entering industry.
Wednesday, November 11, 2020
2:00 PM – 2:30 PM ET